<DOC>
	<DOCNO>NCT02147899</DOCNO>
	<brief_summary>The purpose research study test safety effectiveness oral investigational new drug , SYM-1219 , treatment bacterial vaginosis .</brief_summary>
	<brief_title>A Phase 2 Study SYM-1219 Treat Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<criteria>Are females least 18 year age good general health menopausal . Have clinical diagnosis bacterial vaginosis , define follow criterion : Offwhite ( milky gray ) , thin , homogeneous vaginal discharge Vaginal pH ≥ 4.7 Presence clue cell ≥ 20 % total epithelial cell microscopic examination vaginal saline wet mount A positive 10 % KOH Whiff test . Have Gram stain slide Nugent score ≥ 4 Baseline visit ( Day 1 ) Are pregnant , lactating , plan become pregnant study . Are suspect clinically ( confirm diagnostically ) alternative cause vaginal symptom include candidiasis , Chlamydia trachomatis , Trichomonas vaginalis , Neisseria gonorrhoeae Herpes simplex . Have receive antifungal antimicrobial therapy ( systemic intravaginal ) within 14 day prior Baseline visit ( Day 1 ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>